Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology

被引：0
|
作者：
Sankawa, Yuri
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [31] Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy for All?
    Nooshin Hashemi-Sadraei
    Nathan A. Pennell
    Current Treatment Options in Oncology, 2012, 13 : 478 - 490
  • [32] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [33] Evaluating inflammatory markers as predictive tools for advanced non-small cell lung cancer receiving nivolumab Predictive markers for nivolumab response in advanced NSCLC
    Karaboyun, Kubilay
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 : 361 - 365
  • [34] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [35] Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)
    Thomas, M.
    Kohlhaeufl, M.
    Reck, M.
    Engel-Riedel, W.
    Kortsik, C.
    Bullinger, L.
    Schneider, C. -P.
    Felip, E.
    Brahmer, J.
    Vokes, E.
    Gettinger, S.
    Geese, W.
    Yoon, D.
    Healey, D.
    Li, A.
    Eberhardt, W. E. E.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 137 - 137
  • [36] "Realworld" application of nivolumab and the impact of performance status on outcomes of in patients with advanced non-small cell lung cancer (NSCLC)
    Abbas, Nazim
    Roy, Amitesh
    Klevansky, Myron
    Vatandoust, Sina
    Kichenadasse, Ganessan
    Koczwara, Bogda
    Sukumaran, Shawgi
    Karapetis, Chris
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 82 - 82
  • [37] Examination of patients with advanced non-small cell lung cancer (NSCLC) responding to nivolumab monotherapy over 1 year
    Nakajima, Saki
    Watanabe, Satoshi
    Utsunomiya, Takuhide
    Yoshinoya, Kiyokazu
    Honda, Hidehiro
    Yamamoto, Suguru
    Kudo, Keita
    ANNALS OF ONCOLOGY, 2022, 33 : S536 - S536
  • [38] Hyper-progressive disease in patients with advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo)
    Costantini, Adrien
    Corny, Jennifer
    Fallet, Vincent
    Renet, Sophie
    Friard, Sylvie
    Chouaid, Christos
    Duchemann, Boris
    Giroux-Leprieur, Etienne
    Taillade, Laurent
    Doucet, Ludovic
    Nguenang, Marina
    Jouveshomme, Stephane
    Wislez, Marie
    Tredaniel, Jean
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [39] Measures of aggressive care in advanced non-small cell lung cancer (NSCLC) patients
    McCannon, J.
    Jackson, V. A.
    Billings, J. A.
    Pirl, W. F.
    Greer, J.
    Lynch, T. J.
    Temel, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] FUNCTIONAL DECLINE IN PATIENTS WITH ADVANCED STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Murnane, A.
    Krishnasamy, M.
    Denehy, L.
    Granger, C.
    Aranda, S.
    Mileshkin, L.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S27 - S28
12345